���ϳԹ���

CLEVELAND - Fred C. Rothstein, MD, President, University Hospitals Case Medical Center, and Pamela B. Davis, MD, PhD, Dean, ���ϳԹ��� School of Medicine, announce the appointment of James Levine, MD, PhD, as Chief of the Division of Endocrinology in the Department of Medicine. ...

CLEVELAND - Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the ���ϳԹ��� School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) har...

CLEVELAND - One third of the world’s population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from ���ϳԹ��� School of Medicine, offers hope for new approac...

CLEVELAND - A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease (CJD) was reported in the 1920s. The landmark finding from the...

CLEVELAND - Researchers at ���ϳԹ��� developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drug...

CLEVELAND - Jonathan Stamler, MD, Director of the Institute for Transformative Molecular Medicine and the Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation at the ���ϳԹ��� and University Hospitals Harrington-McLaughlin Heart & V...

CLEVELAND - The ���ϳԹ���/University Hospitals Case Medical Center Center for AIDS Research (CFAR) announced today it has received a five-year renewal grant from the National Institutes of Health (NIH) for $9 million. The CFAR provides clinical and technological support to rese...

CLEVELAND - Cynthia Owusu, MD, associate professor at ���ϳԹ��� and geriatric-oncologist at University Hospitals Case Medical Center, the School’s primary affiliate, has received nearly $500,000 from Susan G. Komen For the Cure to fund a novel three-year study aimed at improvin...

CLEVELAND - Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostat...

CLEVELAND - Using chemical labeling and mass spectrometry-based techniques, Mark Chance, PhD, director of the ���ϳԹ��� School of Medicine Center for Proteomics and Bioinformatics and professor of physiology and biophysics; Sayan Gupta, PhD, instructor at the Case Center for Pr...